U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C14H21NO2
Molecular Weight 235.322
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AMYLOCAINE

SMILES

CCC(C)(CN(C)C)OC(=O)C1=CC=CC=C1

InChI

InChIKey=FDMBBCOBEAVDAO-UHFFFAOYSA-N
InChI=1S/C14H21NO2/c1-5-14(2,11-15(3)4)17-13(16)12-9-7-6-8-10-12/h6-10H,5,11H2,1-4H3

HIDE SMILES / InChI

Description
Curator's Comment: The description was created based on several sources, including https://www.drugs.com/international/amylocaine.html | https://www.ncbi.nlm.nih.gov/pubmed/15957711 | https://www.ncbi.nlm.nih.gov/pubmed/9068339 | https://www.ncbi.nlm.nih.gov/pubmed/8881614

Amylocaine (trade name Stovaine) is a local anesthetic, that was widely used for spinal anesthesia in Caesarean section. The dose used would produce anesthesia for up to 1 h. Reports of the use of spinal analgesia for abdominal and perineal surgery in infants are found from several centers during the first half of the twentieth century. However, this agent often fails to provide good maternal sensory block and currently, Amylocaine has been replaced with new anesthetics.

Originator

Sources: Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences (1904), 138, 766-768.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Stovaine

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Local anaesthesia after cocaine.
2004 Apr
[The effects of the success of the synthesis of Stovaïne in science and industry. Ernest Fourneau (1872-1949) and the transformation of the field of medicinal chemistry in France].
2007
Patents

Patents

Sample Use Guides

5, 10, or 20 mg/kg
Route of Administration: Intravenous
In Vitro Use Guide
Female Wistar rats Cerebral cortex homogenate were used for activity evaluation. Binding assays were performed in 1-ml volumes of Tris HC1 buffer for 90 min at 20°C using cere- brocortical membranes containing approximately 200 mkg of protein. After incubation, each sample was filtered under vacuum through Whatman GF/B filters using a Brandel cell harvester to separate bound and free radioactivity. Filter retained (bound) radioactivity was extracted for at least 8 h in 4 ml of scintillation fluid before estimation using a beta-scintillation counter. Estimated radioactivity was quench cor¬rected with an average [3H] counting efficiency of 60.4%. In order to determine if local anaesthetics interacted with DHP binding sites on L-type Ca2+ channels, the DHP binding site was labelled with [3H]PN200-110. Increasing concentrations of unlabelled displacer (local anaesthetics) were then added. Displacement of [3H]PN200-110 binding by local anaesthetics indicates that they are interact-ing at the same site as the radiolabel. A fixed concentration of [3H]PN200-110 (approximately 0.2 nmol litre-1) was displaced by the following unlabelled agents Amylocaine (30-10000mkM)
Name Type Language
AMYLOCAINE
MI   WHO-DD  
Common Name English
AMYLOCAINE [MI]
Common Name English
Amylocaine [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C245
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
Code System Code Type Description
MERCK INDEX
m1877
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
PRIMARY Merck Index
SMS_ID
100000077416
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
PRIMARY
WIKIPEDIA
AMYLOCAINE
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
PRIMARY
DRUG BANK
DB09088
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
PRIMARY
CAS
644-26-8
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
PRIMARY
DRUG CENTRAL
206
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
PRIMARY
FDA UNII
QRW683O56T
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
PRIMARY
MESH
C015677
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
PRIMARY
ECHA (EC/EINECS)
211-411-1
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
PRIMARY
EVMPD
SUB12893MIG
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
PRIMARY
RXCUI
40660
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
PRIMARY RxNorm
PUBCHEM
10767
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
PRIMARY
EPA CompTox
DTXSID6047862
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
PRIMARY
ChEMBL
CHEMBL1740065
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
PRIMARY
NCI_THESAURUS
C72170
Created by admin on Fri Dec 15 15:37:07 GMT 2023 , Edited by admin on Fri Dec 15 15:37:07 GMT 2023
PRIMARY